Literature DB >> 15647181

Reduced expression of epidermal growth factor receptor related protein in gastric cancer.

W S Moon1, A S Tarnawski, J Chai, J T Yang, A P N Majumdar.   

Abstract

OBJECTIVES: The recently cloned epidermal growth factor receptor related protein (ERRP) has been proposed to be a negative regulator of the epidermal growth factor receptor (EGFR). Because of the causal involvement of EGFR and its ligands in gastric cancer growth, we investigated expression of ERRP and cell proliferation in human gastric cancer.
METHODS: We examined ERRP expression and localisation in surgical specimens of gastric cancers from 47 patients versus non-malignant gastric mucosa and determined their relationship to cell proliferation and differentiation. We also examined expression of ERRP by western blotting in three different gastric cancer cell lines. To further determine the functional properties of ERRP, we examined the effect of ERRP on epidermal growth factor (EGF) induced EGFR phosphorylation essential for its activation in MKN-28 gastric cancer cells.
RESULTS: ERRP expression was dramatically reduced in gastric cancers (34% of all specimens positive) compared with non-malignant gastric mucosa (66% of specimens positive). Expression of ERRP in cancer cells inversely correlated with cell proliferation and grade of malignancy. Cell lines derived from metastatic gastric cancers had reduced ERRP expression compared with cell lines derived from a non-metastatic cancer. Exogenous ERRP protein markedly inhibited EGF induced EGFR phosphorylation in gastric cancer cells providing a novel molecular mechanism of its action.
CONCLUSIONS: Our data indicate that downregulation of ERRP could play an important role in gastric cancer differentiation and progression. ERRP is a negative regulator of tumour cell proliferation and may exert its inhibitory effect, in part, by attenuating EGFR activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15647181      PMCID: PMC1774858          DOI: 10.1136/gut.2003.027078

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  Expression of ERRP in normal and neoplastic pancreata and its relationship to clinicopathologic parameters in pancreatic adenocarcinoma.

Authors:  J Feng; N V Adsay; M Kruger; K L Ellis; K Nagothu; A P N Majumdar; F H Sarkar
Journal:  Pancreas       Date:  2002-11       Impact factor: 3.327

3.  Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum.

Authors:  M Wagner; T Cao; M E Lopez; C Hope; K van Nostrand; M S Kobrin; H U Fan; M W Büchler; M Korc
Journal:  Int J Cancer       Date:  1996-12-11       Impact factor: 7.396

4.  A 1.8 kb alternative transcript from the human epidermal growth factor receptor gene encodes a truncated form of the receptor.

Authors:  J L Reiter; N J Maihle
Journal:  Nucleic Acids Res       Date:  1996-10-15       Impact factor: 16.971

5.  Cloning of a novel EGFR-related peptide: a putative negative regulator of EGFR.

Authors:  Y Yu; A K Rishi; J R Turner; D Liu; E D Black; J A Moshier; A P Majumdar
Journal:  Am J Physiol Cell Physiol       Date:  2001-05       Impact factor: 4.249

6.  Epidermal growth factor receptor-related protein: a potential therapeutic agent for colorectal cancer.

Authors:  Dorota J Marciniak; Lathika Moragoda; Ramzi M Mohammad; Yingjie Yu; Kiran K Nagothu; Amro Aboukameel; Fazlul H Sarkar; Volkan N Adsay; Arun K Rishi; Adhip P n Majumdar
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

7.  A truncated, secreted form of the epidermal growth factor receptor is encoded by an alternatively spliced transcript in normal rat tissue.

Authors:  L A Petch; J Harris; V W Raymond; A Blasband; D C Lee; H S Earp
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

8.  Expression of EGF-receptor related protein (ERRP) decreases in gastric mucosa during aging and carcinogenesis.

Authors:  Adhip P N Majumdar; Jianhua Du; James S Hatfield; Edi Levi; Volkan Adsay; Eva M Schmelz; Kiran K Nagothu; Richard Jaszewski; Omer Kucuk; Fazlul H Sarkar
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

9.  Intracellular and interstitial expression of Helicobacter pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma.

Authors:  Cristina Semino-Mora; Sonia Q Doi; Aileen Marty; Vlado Simko; Ingemar Carlstedt; Andre Dubois
Journal:  J Infect Dis       Date:  2003-04-02       Impact factor: 5.226

10.  Growth of human gastric carcinomas and expression of epidermal growth factor, transforming growth factor-alpha, epidermal growth factor receptor and p185c-erbB-2.

Authors:  T Suzuki; T Tsuda; K Haruma; M Yoshihara; K Sumii; G Kajiyama
Journal:  Oncology       Date:  1995 Sep-Oct       Impact factor: 2.935

View more
  3 in total

Review 1.  Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy.

Authors:  J C Becker; C Muller-Tidow; H Serve; W Domschke; T Pohle
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

Review 2.  Emerging therapies in gastrointestinal cancers.

Authors:  Jyoti Nautiyal; Arun K Rishi; Adhip P N Majumdar
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

3.  Activation of EGFR and ERBB2 by Helicobacter pylori results in survival of gastric epithelial cells with DNA damage.

Authors:  Rupesh Chaturvedi; Mohammad Asim; M Blanca Piazuelo; Fang Yan; Daniel P Barry; Johanna Carolina Sierra; Alberto G Delgado; Salisha Hill; Robert A Casero; Luis E Bravo; Ricardo L Dominguez; Pelayo Correa; D Brent Polk; M Kay Washington; Kristie L Rose; Kevin L Schey; Douglas R Morgan; Richard M Peek; Keith T Wilson
Journal:  Gastroenterology       Date:  2014-02-13       Impact factor: 22.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.